Citigroup Inc Sana Biotechnology, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Citigroup Inc holds 105,145 shares of SANA stock, worth $247,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,145

Previous 355,328 70.41%

Holding current value

$247,090

Previous $1.94 Million 77.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.76 - $6.86 $940,688 - $1.72 Million	-250,183 Reduced 70.41%	105,145 $437,000
Q2 2024 Aug 12, 2024	SELL	$5.23 - $10.44 $598,008 - $1.19 Million	-114,342 Reduced 24.35%	355,328 $1.94 Million
Q1 2024 May 10, 2024	BUY	$4.2 - $11.27 $1.18 Million - $3.15 Million	279,770 Added 147.32%	469,670 $4.7 Million
Q4 2023 Feb 09, 2024	BUY	$2.8 - $4.55 $124,683 - $202,611	44,530 Added 30.63%	189,900 $774,000
Q3 2023 Nov 09, 2023	BUY	$3.77 - $6.23 $51,332 - $84,827	13,616 Added 10.33%	145,370 $562,000
Q2 2023 Aug 10, 2023	SELL	$3.22 - $7.53 $666,591 - $1.56 Million	-207,016 Reduced 61.11%	131,754 $785,000
Q1 2023 May 11, 2023	BUY	$3.11 - $4.92 $308,670 - $488,314	99,251 Added 41.44%	338,770 $1.11 Million
Q4 2022 Feb 09, 2023	SELL	$3.19 - $6.46 $527,214 - $1.07 Million	-165,271 Reduced 40.83%	239,519 $946,000
Q3 2022 Nov 10, 2022	BUY	$5.58 - $9.04 $58,813 - $95,281	10,540 Added 2.67%	404,790 $2.43 Million
Q2 2022 Aug 10, 2022	BUY	$4.12 - $9.35 $1.23 Million - $2.79 Million	298,508 Added 311.78%	394,250 $2.54 Million
Q1 2022 May 12, 2022	SELL	$5.24 - $15.58 $500,530 - $1.49 Million	-95,521 Reduced 49.94%	95,742 $791,000
Q4 2021 Feb 10, 2022	BUY	$15.18 - $23.15 $2.07 Million - $3.16 Million	136,687 Added 250.45%	191,263 $2.96 Million
Q3 2021 Nov 10, 2021	BUY	$16.29 - $25.88 $889,043 - $1.41 Million	54,576 New	54,576 $1.23 Million

Others Institutions Holding SANA

# of Institutions

174

Shares Held

121M

Call Options Held

1.87M

Put Options Held

1.48M

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $447M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account